Live Breaking News & Updates on Hospital Nacional De Parapl

Stay updated with breaking news from Hospital nacional de parapl. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Neuroplast successfully completes patient inclusion of Phase II clinical trial for Traumatic Spinal Cord Injury

Neuroplast, a Dutch clinical-stage biotech, focusing on cell-based treatments for neurodegenerative diseases, has successfully completed patient inclusion of its Phase II randomized placebo-controlled double-blinded clinical trial to evaluate the effect size of Neuro-Cells® for Traumatic Spinal Cord Injury (TSCI) . ....

Antonio Oliviero , Claus Andersen , Traumatic Spinal Cord Injury , Hospital Nacional De Parapl , Principal Investigators Antonio Oliviero , Hospital Parapl , Professor Fin Biering S , Phd Claus Andersen , Principal Investigator ,

Neuroplast successfully completes patient inclusion of Phase II clinical trial for Traumatic Spinal Cord Injury

16 patients have been enrolled in a multicenter international, randomized, placebo-controlled, double-blinded Phase II clinical trial Goal: to determine the. ....

United States , Noord Holland , Claus Andersen , Antonio Oliviero , Erik Wolters , Netherlands Enterprise Agency , Brightlands Agrifood Fund , Dutch Ministry Of Economic Affairs , Traumatic Spinal Cord Injury , Hospital Nacional De Parapl , Principal Investigators Antonio Oliviero , Hospital Parapl , Professor Fin Biering S , Phd Claus Andersen , Principal Investigator , Johannes De Munter , Lumana Invest , Brightlands Venture Partners , Netherlands Enterprise , Hospital De Parapl , Nacional De Parapl , Venture Partners , Chemelot Ventures , Dutch Ministry , Economic Affairs , Spring Lifesciences Communication ,

Neuroplast spinal cord injury study milestone

Neuroplast spinal cord injury study milestone
pharmatimes.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pharmatimes.com Daily Mail and Mail on Sunday newspapers.

Antonio Oliviero , Hospital Nacional De Parapl ,

First patient in stem cell trial for treatment of Traumatic Spinal Cord Injury

Neuroplast has enrolled its first patient in a Phase II clinical trial to evaluate efficacy of its transformative Neuro-Cells® treatment that aims to ....

United States , Agencia Espa , Antonio Oliviero , Medicamentosy Productos Sanitarios , National Videnskabsetisk Komit , Danish Medicines Agency , Traumatic Spinal Cord Injury , Hospital Nacional De Parapl , Principal Investigators Antonio Oliviero , Hospital Parapl , Principal Investigator , Spinal Cord Injury , Spinal Cord , Productos Sanitarios , Danish Medicines , Johannes De Munter , Traumatic Brain Injury ,

Stem cell biotech Neuroplast enrolls first patient in Phase II clinical trial of transformative Neuro-Cells treatment for Traumatic Spinal Cord Injury

Neuro-Cells treatment aims to reduce irreversible damage to the central nervous system from secondary inflammation following traumaThe randomized, placebo-controlled, international multi-center ....

United States , Noord Holland , Kostenloser Wertpapierhandel , Erik Wolters , Prnewswire Neuroplast , Antonio Oliviero , Medicamentosy Productos Sanitarios , Brightlands Agrifood Fund , National Videnskabsetisk Komit , Netherlands Enterprise Agency , Danish Medicines Agency , Dutch Ministry Of Economic Affairs , Traumatic Spinal Cord Injury , Traumatic Brain Injury , Frontotemporal Dementia , Hospital Nacional De Parapl , Principal Investigators Antonio Oliviero , Hospital Parapl , Principal Investigator , Spinal Cord Injury , Spinal Cord , Agencia Espanola De Medicamentos , Productos Sanitarios , Danish Medicines , Johannes De Munter , Lumana Invest ,